38024-62-3

Basic information

• Product Name: 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrion e
• Synonyms: 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrion e
• CAS NO: 38024-62-3
• Molecular Formula: C₂₆H₂₄N₂O₃
• Molecular Weight: 412.48
• Mol File: 38024-62-3.mol

Chemical Properties

• Boiling Point: 568.1°Cat760mmHg
• Flash Point: 240.5°C
• Appearance: /
• Density: 1.231g/cm³
• Vapor Pressure: 6.4E-13mmHg at 25°C
• Refractive Index: 1.622
• PKA: -2.56±0.40(Predicted)
• CAS DataBase Reference: 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrion e(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrion e(38024-62-3)
• EPA Substance Registry System: 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrion e(38024-62-3)

Safety Data

• Hazardous Substances Data: 38024-62-3(Hazardous Substances Data)

Usage

Chemical Class

Pyrimidinetrione derivative

Explanation

The compound belongs to a class of organic compounds known as pyrimidinetriones, which are characterized by a six-membered nitrogen-containing ring with three carbonyl groups.

Explanation

The molecular structure of 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione is complex due to the presence of multiple functional groups and substituents.

Explanation

The compound has two phenylmethyl groups, one ethyl group, and one phenyl group attached to the pyrimidine ring, which contribute to its unique properties.

Explanation

Although not widely reported, the compound's unique structure suggests it may have potential biological activity, making it a candidate for further research in pharmaceutical or medicinal applications.

Explanation

The compound's complex structure and potential biological activity make it a subject of interest for researchers in the fields of organic chemistry and drug discovery.

Explanation

The specific uses and effects of 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione have not been extensively documented, indicating the need for further research.

Explanation

The compound has three stereoisomers, designated as 1H, 3H, and 5H, which differ in the orientation of their hydrogen atoms.

Explanation

The solubility of 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione in various solvents is not specified in the provided material.

Explanation

The stability of the compound under different conditions, such as temperature, pH, or exposure to light, is not mentioned in the provided material.

Explanation

The synthesis method for 1,3-Bis(phenylmethyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione is not described in the provided material.

Molecular Structure

Complex

Substituents

Phenylmethyl, Ethyl, Phenyl

Biological Activity

Potential

Research Field

Organic Chemistry and Drug Discovery

Specific Uses

Not widely reported

Stereoisomers

1H, 3H, 5H

Solubility

Unknown

Stability

Unknown

Synthesis

Not specified

InChI:InChI=1/C26H24N2O3/c1-2-26(22-16-10-5-11-17-22)23(29)27(18-20-12-6-3-7-13-20)25(31)28(24(26)30)19-21-14-8-4-9-15-21/h3-17H,2,18-19H2,1H3

Upstream product

• 50-06-6 phenobarbital 
• 100-44-7 benzyl chloride 

Relevant articles and documents

Anticonvulsants. IV. Metharbital and phenobarbital derivatives

Several metharbital and phenobarbital derivatives were found to possess potent anticonvulsant activity and yet were either devoid of the marked hypnotic effects of the parent compounds or displayed very weak hypnotic activity. Particularly active compounds were the monomethoxymethyl derivative of phenobarbital, the 1 methyl 3 butoxymethyl derivative of phenobarbital, and the 3 methoxymethyl derivative of metharbital.